The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation
2006

DOTS Strategy for Tuberculosis in Samara, Russia

Sample size: 2099 publication Evidence: moderate

Author Information

Author(s): Y Balabanova, F Drobniewski, I Fedorin, S Zakharova, V Nikolayevskyy, R Atun, R Coker

Primary Institution: HPA Mycobacterium Reference Unit, Clinical TB and HIV Group, St Bartholomew and Queen Mary School of Medicine

Hypothesis

Can the DOTS program improve tuberculosis treatment outcomes in Samara, Russia?

Conclusion

The implementation of DOTS in Samara, Russia, was feasible and successful, but drug-resistant tuberculosis rates were high.

Supporting Evidence

  • 75.3% of patients were successfully treated under the DOTS program.
  • 24.9% of new cases were isoniazid resistant.
  • Drug resistance was strongly associated with infection from the Beijing strain.

Takeaway

This study shows that a new treatment program helped many people with tuberculosis in Russia, but some still had tough-to-treat infections.

Methodology

A prospective study was conducted to implement the DOTS program and analyze treatment outcomes.

Potential Biases

Potential bias due to the transfer of patients to individualized treatment regimens.

Limitations

The study was limited to patients recruited until the third quarter of 2003, and outcomes for later patients were recorded under a different system.

Participant Demographics

The mean age of participants was 38.5 years, with 80.2% being men and 19.8% women; 30.5% were prisoners.

Statistical Information

Confidence Interval

95% CI 37.9–39.1 years

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-7-44

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication